Origin BioMed Selected Top Canadian Business at Red Herring Awards

September 22, 2008 - Halifax, NS - Origin BioMed Inc., a privately-held Canadian consumer health products company, was honoured at the second annual Red Herring Top 50 Canada Awards held in Mont-Tremblant, Quebec, on September 16. Red Herring, the leading California technology publication, named Origin BioMed Inc. the most innovative and promising technology company in Canada in its category.

The Red Herring editorial team used an intensely competitive process to select the most innovative companies. The nominees were rigidly evaluated on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy, and integration into their ecosystem.

“Since its inception, Origin’s mission has been to leverage cutting edge technology to bring scientifically proven natural products to professional care givers and consumers. We strive to increase over-the-counter treatment options for nerve pain, and Red Herring’s recognition demonstrates that our model drives novelty and improvement within our industry,” said Robert Cervelli, President and CEO, Origin BioMed. “It was a real honour to accept this award on behalf of the entire team at Origin, who relentlessly focus on moving forward innovations,” he added.

Origin BioMed’s leading drug product, Neuragen®, is the first non-prescription topical treatment for rapid relief of diabetic and post-shingles nerve pain. Neuragen® is available in leading pharmacies in Canada and was recently launched in the United States.

About Origin BioMed Inc.

Origin BioMed, Inc. is a privately-held Canadian consumer health products company with business operations throughout the U.S. and Canada. Headquartered in Halifax, Nova Scotia, Origin BioMed Inc. manufactures health products with the highest quality active ingredients, at therapeutic levels, with evidence of scientific or clinical efficacy since 2001. Its leading drug product, Neuragen®, helps relieve pain caused by diabetic nerve damage. For more information, please visit: www.originbiomed.com or www.neuragen.com.

NEWS | ABOUT | TEAM | INVESTMENT CRITERIA | PORTFOLIO | CONTACT




Origin BioMed Selected Top Canadian Business at Red Herring Awards

September 22, 2008 - Halifax, NS - Origin BioMed Inc., a privately-held Canadian consumer health products company, was honoured at the second annual Red Herring Top 50 Canada Awards held in Mont-Tremblant, Quebec, on September 16. Red Herring, the leading California technology publication, named Origin BioMed Inc. the most innovative and promising technology company in Canada in its category.

The Red Herring editorial team used an intensely competitive process to select the most innovative companies. The nominees were rigidly evaluated on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy, and integration into their ecosystem.

“Since its inception, Origin’s mission has been to leverage cutting edge technology to bring scientifically proven natural products to professional care givers and consumers. We strive to increase over-the-counter treatment options for nerve pain, and Red Herring’s recognition demonstrates that our model drives novelty and improvement within our industry,” said Robert Cervelli, President and CEO, Origin BioMed. “It was a real honour to accept this award on behalf of the entire team at Origin, who relentlessly focus on moving forward innovations,” he added.

Origin BioMed’s leading drug product, Neuragen®, is the first non-prescription topical treatment for rapid relief of diabetic and post-shingles nerve pain. Neuragen® is available in leading pharmacies in Canada and was recently launched in the United States.

About Origin BioMed Inc.

Origin BioMed, Inc. is a privately-held Canadian consumer health products company with business operations throughout the U.S. and Canada. Headquartered in Halifax, Nova Scotia, Origin BioMed Inc. manufactures health products with the highest quality active ingredients, at therapeutic levels, with evidence of scientific or clinical efficacy since 2001. Its leading drug product, Neuragen®, helps relieve pain caused by diabetic nerve damage. For more information, please visit: www.originbiomed.com or www.neuragen.com.